Press releases worldwide
Kuros Biosciences today announced it will unveil new research on the role of osteoimmunology in bone formation in three presentations at the North American Spine Society (NASS) 2020 Annual Meeting, held virtually, October 6-9. Kuros is a leader in next […]
MagnetOs Granules and MagnetOs Putty receive TGA approval in Australia Initial launch of MagnetOs on the Australian market scheduled for late Q1 2021. Kuros Biosciences BV, the Dutch subsidiary of Kuros Biosciences AG (SIX: KURN), today announced that MagnetOs Granules […]
Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies, will host an expert perspectives webinar on pioneering solutions for targeted and controlled bone healing on Wednesday, October 14, 2020 at 2pm Central European Time (CET). The call […]
Strong adoption by spinal surgeons since U.S. launch in September 2019 Sales accelerating with over 2,000 patients treated to date Kuros Biosciences (SIX: KURN) today announced that over 2,000 patients have been treated worldwide with its MagnetOs bone graft, an […]
Kuros Biosciences (SIX: KURN) today announced that it will hold an Extraordinary General Meeting (EGM) of shareholders to seek approval to increase the Company’s ordinary share capital. The EGM will be held at Kuros Biosciences AG, Wagistrasse 25, 8952 Schlieren, […]
First investigational trial of a drug-biologic bone graft for spine fusion Phase 2 trial in the U.S. compares Fibrin-PTH (KUR-113) with local autograft Primary endpoint is radiographic interbody fusion at 12 months Potential to address a major commercial opportunity Kuros […]
CHF 16.0 million cash & cash equivalents, trade and other receivables as at June 30, 2020 Revenues increased to CHF 1.3 million driven by strong MagnetOs sales, up 42% versus H1 2019 Net operating costs of CHF 7.5 million led […]
. Grant of European patent entitled ‘Osteoinductive composites’ Notice of allowance of Japanese patent from the same patent family Further strengthens Kuros’s position as a leader in the field of orthobiologics Kuros Biosciences (SIX: KURN) today announced that its Dutch […]
Grant of US patent covering the use of PTH containing matrices for spinal fusion Grant of US patent covering osteoinductive materials made by certain methods Further strengthens Kuros’s position as a leader in the field of orthobiologics Kuros Biosciences (SIX: […]